Page 34 - Topline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Attorney general mark brnovich thanks so much for joining the program you're one of the 14ag callings homeland security secretary -- to resign tell me about this breaking news about repealing 42 what is your quick topline thoughtings on it? >> title 42 is one of the last remaining toolings that we have in our tool box to stop this catastrophe at the southern border is we all know that more than 2 million people entered if this policy is resngd we will see 500,000 additional people illegally enter our country essentially entire population of a place like kansas city, missouri. so what the left ...

Attorney general mark brnovich thanks so much for joining the program you're one of the 14ag callings homeland security secretary -- to resign tell me about this breaking news about repealing 42 what is your quick topline thoughtings on it? >> title 42 is one of the last remaining toolings that we have in our tool box to stop this catastrophe at the southern border is we all know that more than 2 million people entered if this policy is resngngd we will see 500,000 additional people illegally enter our country essentially entire population of a place like kansas city, missouri. so what the lef...

Now i want to bring in arizona attorney general mark brnovich thanks so much for joining the program you're one of the 14ag callings homeland security secretary -- to resign tell me about this breaking news about repealing 42 what is your quick topline thoughtings on it? >> title 42 is one of the last remaining toolings that we have in our tool box to stop this catastrophe at the southern border is we all know that more than 2 million people entered if this policy is resngd we will see 500,000 additional people illegally enter our country essentially entire population of a place like kansas ci...

Cystic Fibrosis Foundation to provide an award of up to $15.9 million for the ongoing ELX-02 clinical program Expect topline data from cystic fibrosis Phase 2 expansion treatment arms evaluating... | March 29, 2022

BIIB078, an investigational antisense oligonucleotide for C9orf72-associated amyotrophic lateral sclerosis (ALS), did not show clinical benefit; clinical program will be discontinuedBiogen and Ionis remain